For research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use.
Menu
Reconstitution calculator
Guide

Peptide Beginner's Guide: Vials, Supplies, Evidence and Safety Basics

A plain-language orientation to peptide vials, reconstitution, storage, syringes, certificates of analysis and how to judge the evidence behind a protocol.

This guide is an orientation, not a regimen. It explains the vocabulary, the physical steps between a sealed vial and a measured volume, and how to judge the quality of the evidence behind anything you read, including on this site. It does not tell you what to do for your own body. Every protocol page on PeptideCheck shows its citation and an evidence grade next to each figure; this guide explains how to read those grades.

What you are actually dealing with

A peptide is a short chain of amino acids. The compounds covered on this site range from approved prescription drugs (for example the once-weekly GLP-1 class and a growth-hormone-releasing-factor analogue) to research materials that have never been through an approval process. Those two groups have very different documentation, and mixing them up is the most common beginner error.

  • Approved drugs come with a label that states the diluent, the volumes, the storage temperature and the discard time for that exact product. The label is the best available source and always outranks any website, including this one.
  • Research materials are sold with research-use-only labelling. They have no approved label. FDA has placed several of these peptides on its list of bulk drug substances that may present significant safety risks; for GHRP-2, GHRP-6 and ipamorelin the entries were added on September 29, 2023, with FDA citing immunogenicity risk from aggregation and peptide-related impurities, and, for ipamorelin, serious adverse events including death after intravenous administration.[1]
  • Compounded drugs are a third category. FDA states that compounded drugs are not approved by FDA, meaning FDA does not review them for safety, effectiveness or quality before they reach patients.[2]

A narrative review of peptides sold as "research compounds" for the GH-IGF-1 axis describes the products as often having uncertain purity, dose consistency and sterility, and says sterility cannot be assumed in informal distribution channels.[3] That is why quality documents (see how to read a COA) matter more than marketing copy.

How the evidence is graded on this site

Every dose, frequency, duration, storage figure and side effect on a protocol page carries a letter grade:

GradeMeaning
AApproved drug label
BHuman clinical trial
CHuman observational study, case series or review
DAnimal or in vitro study
ECommunity-reported, with a public source. Labelled "Community-reported, not clinically validated"

A 2026 review of therapeutic peptides in ageing concluded that non-approved peptides have mainly preclinical or limited clinical evidence and lack long-term safety data, and named optimal dosing, combination effects and monitoring biomarkers as key gaps.[9] Read a grade D or E figure as a description of what a source reports, not as something validated for people.

The physical workflow, in order

Most beginner mistakes happen in one of six steps. Each has its own guide.

  1. Identify and document. Match the vial label to the compound, the lot and a certificate of analysis. A COA reports identity, purity, content and, on newer formats, endotoxin and sterility. See how to read a COA and the COA library.
  2. Store the sealed vial correctly. Bachem advises storing lyophilised peptides below -15 °C for maximum stability and allowing the container to reach room temperature before opening.[4] Approved products differ: the EGRIFTA WR label says room temperature at 20 to 25 °C in the original box, protected from light.[5] The rule is to follow the document for the specific product. See peptide storage.
  3. Reconstitute. Lyophilised powder is mixed with a diluent. The label for one approved lyophilised peptide specifies Bacteriostatic Water for Injection and mixing by swirling, not shaking.[5] See how to reconstitute peptides and the reconstitution calculator.
  4. Convert volume to syringe markings. Standard insulin syringes are calibrated to 100 units per 1 mL (U-100).[7] See the syringe units guide and the units tool.
  5. Inject with clean technique. CDC advises aseptic technique when preparing and giving injections.[6] See injection technique.
  6. Record what you do. Date the vial, record the concentration and note any reaction. The storage timer helps with beyond-use dates.

Why the diluent and the vial date matter

A multi-dose vial of bacteriostatic diluent is not a permanent supply. CDC's multi-dose vial guidance, drawing on USP General Chapter 797, says the vial should be dated and discarded within 28 days.[6] The EGRIFTA WR instructions repeat the same limit for the supplied bacteriostatic water bottle: discard after 28 days of use.[5] See the BAC water guide.

Reading a certificate of analysis in one minute

A COA is a lab report for one lot. On COA10238 (a four-component blend), the lab states identity confirmed by LC-MS/MS, purity by RP-HPLC at 214 nm of 98.82%, endotoxin below 0.05 EU/mL by USP 85, and sterility not detected by USP 71.[8] Purity is not content, and neither is identity; the COA guide separates them. Check that the lot number on the report matches the lot on your vial, and use the COA checker for the verification steps.

Common questions

Does a higher purity number mean a safer product?

Not by itself. Purity is the share of the target peptide among UV-absorbing species in one HPLC run. It does not measure water or counter-ion content, sterility or endotoxin, and it says nothing about whether the compound has been tested in people.

Why do two labels give different storage advice?

Because they describe different products. One approved product says do not freeze or refrigerate after mixing, while a general peptide-handling note says peptide solutions should be aliquoted and kept frozen below -15 °C if they must be stored.[4][5] The specific label wins; a general note is a default for peptides without a label.

Where do I look for a compound's cited numbers?

Open the compound hub under /peptides/. Each figure links to its source and shows its grade. The dosage chart collects them, and the glossary defines the terms used throughout.

What to do when the information is thin

For many compounds the honest answer is that no published human dose-finding trial exists. In that case the site shows animal data separately and labels community-reported ranges as grade E. If a figure has no source it is left blank rather than estimated. If you are weighing a decision about your own health, an approved product's label and a licensed clinician are the appropriate authorities, and no website, including this one, replaces them.

Where to go next

References

  1. FDA: Certain bulk drug substances for use in compounding that may present significant safety risks (category 2 list, current as of 04/22/2026)
  2. FDA: Human drug compounding laws (sections 503A and 503B)
  3. Frontiers in Endocrinology 2026: The emerging landscape of performance-enhancing peptides modulating the GH-IGF1 axis (PMC13322892)
  4. Bachem: Care and handling of peptides
  5. EGRIFTA WR (tesamorelin) US prescribing information, FDA, revised March 2025
  6. CDC: Injection safety, clinical safety recommendations
  7. MedlinePlus: Giving an insulin injection (reviewed 7/21/2024)
  8. Certificate of analysis COA10238 (Bioviridian, lot 697, issued October 12, 2026), supplier-published
  9. Frontiers in Aging 2026: Therapeutic peptides in gerontology (PMID 42021992)

More guides